View in EDS

Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancer.

Saved in:
Bibliographic Details
Title: Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancer.
Authors: Matos AI; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisbon, Portugal., Carreira B; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisbon, Portugal., Peres C; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisbon, Portugal., Moura LIF; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisbon, Portugal., Conniot J; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisbon, Portugal., Fourniols T; Louvain Drug Research Institute, Advanced Drug Delivery & Biomaterials, Université Catholique de Louvain, 1200 Brussels, Belgium., Scomparin A; Department of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel; Department of Drug Science and Technology, University of Turin, Via P. Giuria 9, 10125 Turin, Italy., Martínez-Barriocanal Á; Group of Biomedical Research in Digestive Tract Tumors, CIBBIM-Nanomedicine, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona (UAB), Barcelona 08035, Spain., Arango D; Group of Biomedical Research in Digestive Tract Tumors, CIBBIM-Nanomedicine, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona (UAB), Barcelona 08035, Spain., Conde JP; Instituto de Engenharia de Sistemas E Computadores - Microsistemas e Nanotecnologias (INESC MN), IN - Institute of Nanoscience and Nanotechnology, Rua Alves Redol, 9, 1000-029 Lisbon, Portugal; Department of Bioengineering, Instituto Superior Tecnico, University of Lisbon, 1049-001 Lisbon, Portugal., Préat V; Louvain Drug Research Institute, Advanced Drug Delivery & Biomaterials, Université Catholique de Louvain, 1200 Brussels, Belgium., Satchi-Fainaro R; Department of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel. Electronic address: ronitsf@tauex.tau.ac.il., Florindo HF; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisbon, Portugal. Electronic address: hflorindo@ff.ulisboa.pt.
Source: Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2019 Aug 10; Vol. 307, pp. 108-138. Date of Electronic Publication: 2019 Jun 19.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
Journal Info: Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8607908 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4995 (Electronic) Linking ISSN: 01683659 NLM ISO Abbreviation: J Control Release Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 31226355
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Matos+AI%22">Matos AI</searchLink>; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Carreira+B%22">Carreira B</searchLink>; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Peres+C%22">Peres C</searchLink>; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Moura+LIF%22">Moura LIF</searchLink>; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Conniot+J%22">Conniot J</searchLink>; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Fourniols+T%22">Fourniols T</searchLink>; Louvain Drug Research Institute, Advanced Drug Delivery & Biomaterials, Université Catholique de Louvain, 1200 Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Scomparin+A%22">Scomparin A</searchLink>; Department of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel; Department of Drug Science and Technology, University of Turin, Via P. Giuria 9, 10125 Turin, Italy.<br /><searchLink fieldCode="AU" term="%22Martínez-Barriocanal+Á%22">Martínez-Barriocanal Á</searchLink>; Group of Biomedical Research in Digestive Tract Tumors, CIBBIM-Nanomedicine, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona (UAB), Barcelona 08035, Spain.<br /><searchLink fieldCode="AU" term="%22Arango+D%22">Arango D</searchLink>; Group of Biomedical Research in Digestive Tract Tumors, CIBBIM-Nanomedicine, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona (UAB), Barcelona 08035, Spain.<br /><searchLink fieldCode="AU" term="%22Conde+JP%22">Conde JP</searchLink>; Instituto de Engenharia de Sistemas E Computadores - Microsistemas e Nanotecnologias (INESC MN), IN - Institute of Nanoscience and Nanotechnology, Rua Alves Redol, 9, 1000-029 Lisbon, Portugal; Department of Bioengineering, Instituto Superior Tecnico, University of Lisbon, 1049-001 Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Préat+V%22">Préat V</searchLink>; Louvain Drug Research Institute, Advanced Drug Delivery & Biomaterials, Université Catholique de Louvain, 1200 Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Satchi-Fainaro+R%22">Satchi-Fainaro R</searchLink>; Department of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel. Electronic address: ronitsf@tauex.tau.ac.il.<br /><searchLink fieldCode="AU" term="%22Florindo+HF%22">Florindo HF</searchLink>; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisbon, Portugal. Electronic address: hflorindo@ff.ulisboa.pt.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228607908%22">Journal of controlled release : official journal of the Controlled Release Society</searchLink> [J Control Release] 2019 Aug 10; Vol. 307, pp. 108-138. <i>Date of Electronic Publication: </i>2019 Jun 19.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Publishers%22">Elsevier Science Publishers </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8607908 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-4995 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201683659%22">01683659 </searchLink><i>NLM ISO Abbreviation: </i>J Control Release <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31226355
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.jconrel.2019.06.017
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 108
    Titles:
      – TitleFull: Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Matos AI
      – PersonEntity:
          Name:
            NameFull: Carreira B
      – PersonEntity:
          Name:
            NameFull: Peres C
      – PersonEntity:
          Name:
            NameFull: Moura LIF
      – PersonEntity:
          Name:
            NameFull: Conniot J
      – PersonEntity:
          Name:
            NameFull: Fourniols T
      – PersonEntity:
          Name:
            NameFull: Scomparin A
      – PersonEntity:
          Name:
            NameFull: Martínez-Barriocanal Á
      – PersonEntity:
          Name:
            NameFull: Arango D
      – PersonEntity:
          Name:
            NameFull: Conde JP
      – PersonEntity:
          Name:
            NameFull: Préat V
      – PersonEntity:
          Name:
            NameFull: Satchi-Fainaro R
      – PersonEntity:
          Name:
            NameFull: Florindo HF
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 10
              M: 08
              Text: 2019 Aug 10
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-electronic
              Value: 1873-4995
          Numbering:
            – Type: volume
              Value: 307
          Titles:
            – TitleFull: Journal of controlled release : official journal of the Controlled Release Society
              Type: main
ResultId 1